Acadia Pharmaceutica (ACAD): Congress and insider trades
Who in Congress and inside the company traded ACAD, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Acadia Pharmaceutica (ACAD) is a listed stock on NASDAQ.
- 1 member of Congress filed 0 buys and 1 sell of ACAD, the latest published 2022-07-29 (29 July 2022).
- Insiders filed 0 open market buys worth $0 and 15 sells worth $1.9M, the latest filed 2026-08-07 (7 August 2026).
- Data as of 2026-09-29 (29 September 2026).
Congress trades in ACAD
as of 2022-07-29| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 29 Jul 2022 | Chris Jacobs (R-NY) | sell | 1Kâ15K | 42 | n/a |
Nothing matches that search.
Insider trades in ACAD
as of 2026-08-07| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 7 Aug 2026 | Schneyer Mark C. | sell | 14,292 | $29.22 | $418K | n/a |
| 7 Aug 2026 | Schneyer Mark C. | sell | 5,849 | $29.00 | $170K | n/a |
| 31 Jul 2026 | Thompson Elizabeth H.Z. | sell | 16,558 | $26.13 | $433K | n/a |
| 27 May 2026 | Kihara James | sell | 5,401 | $21.18 | $114K | n/a |
| 5 May 2026 | Schneyer Mark C. | sell | 3,506 | $21.79 | $76.4K | n/a |
| 5 May 2026 | Kihara James | sell | 1,332 | $21.79 | $29.0K | n/a |
| 7 Apr 2026 | Schneyer Mark C. | sell | 2,709 | $22.20 | $60.1K | n/a |
| 7 Apr 2026 | Kihara James | sell | 1,030 | $22.20 | $22.9K | n/a |
| 26 Mar 2026 | Owen Adams Catherine | sell | 11,641 | $21.47 | $250K | n/a |
| 26 Mar 2026 | Thompson Elizabeth H.Z. | sell | 3,435 | $21.47 | $73.7K | n/a |
| 26 Mar 2026 | Kihara James | sell | 1,109 | $21.65 | $24.0K | n/a |
| 26 Mar 2026 | Kihara James | sell | 833 | $21.47 | $17.9K | n/a |
| 26 Mar 2026 | Schneyer Mark C. | sell | 4,177 | $21.47 | $89.7K | n/a |
| 26 Mar 2026 | Rhodes Jennifer J | sell | 3,844 | $21.47 | $82.5K | n/a |
| 26 Mar 2026 | Schneyer Mark C. | sell | 3,208 | $21.65 | $69.5K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought ACAD?
0 Congress buys by 1 member and 0 insider buys are on file. The tables on this page list every one.
Did buying ACAD after a disclosure beat the market?
No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.